Literature DB >> 16177811

Poly(ADP-ribose) accumulation and enhancement of postischemic brain damage in 110-kDa poly(ADP-ribose) glycohydrolase null mice.

Andrea Cozzi1, Giulia Cipriani, Silvia Fossati, Giuseppe Faraco, Laura Formentini, Wookee Min, Ulrich Cortes, Zhao-Qi Wang, Flavio Moroni, Alberto Chiarugi.   

Abstract

Poly(ADP-ribose) (PAR) is a polymer synthesized by poly(ADP-ribose) polymerases (PARPs) and metabolized into free adenosine diphosphate (ADP)-ribose units by poly(ADP-ribose) glycohydrolase (PARG). Perturbations in PAR synthesis have been shown to play a key role in brain disorders including postischemic brain damage. A single parg gene but two PARG isoforms (110 and 60 kDa) have been detected in mouse cells. Complete suppression of parg gene causes early embryonic lethality, whereas mice selectively lacking the 110 kDa PARG isoform (PARG(110)(-/-)) develop normally. We used PARG(110)(-/-) mice to evaluate the importance of PAR catabolism to postischemic brain damage. Poly(ADP-ribose) contents were higher in the brain tissue of PARG(110)(-/-) than PARG(110)(+/+) mice, both under basal conditions and after PARP activation. Distal middle cerebral artery occlusion caused higher increase of brain PAR levels and larger infarct volumes in PARG(110)(-/-) mice than in wild-type counterparts. Of note, the brain of PARG(110)(-/-) mice showed reduced heat-shock protein (HSP)-70 and increased cyclooxygenase-2 expression under both control and ischemic conditions. No differences were detected in brain expression/activation of procaspase-3, PARP-1, Akt, HSP-25 and interleukin-1beta. Our findings show that PAR accumulation worsens ischemic brain injury, and highlight the therapeutic potential of strategies capable of maintaining PAR homeostasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16177811     DOI: 10.1038/sj.jcbfm.9600222

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  28 in total

Review 1.  Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities.

Authors:  Amos A Fatokun; Valina L Dawson; Ted M Dawson
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

2.  Mono-galloyl glucose derivatives are potent poly(ADP-ribose) glycohydrolase (PARG) inhibitors and partially reduce PARP-1-dependent cell death.

Authors:  L Formentini; P Arapistas; M Pittelli; M Jacomelli; V Pitozzi; S Menichetti; A Romani; L Giovannelli; F Moroni; A Chiarugi
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

3.  Ischemic neuroprotection by TRPV1 receptor-induced hypothermia.

Authors:  Mirko Muzzi; Roberta Felici; Leonardo Cavone; Elisabetta Gerace; Alberto Minassi; Giovanni Appendino; Flavio Moroni; Alberto Chiarugi
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

4.  Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase.

Authors:  F Moroni; A Cozzi; A Chiarugi; L Formentini; E Camaioni; D E Pellegrini-Giampietro; Y Chen; S Liang; M M Zaleska; C Gonzales; A Wood; R Pellicciari
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 5.  Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going?

Authors:  Paul O Hassa; Sandra S Haenni; Michael Elser; Michael O Hottiger
Journal:  Microbiol Mol Biol Rev       Date:  2006-09       Impact factor: 11.056

Review 6.  Mitochondrial and nuclear cross talk in cell death: parthanatos.

Authors:  Shaida A Andrabi; Ted M Dawson; Valina L Dawson
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 7.  Novel neuroprotective strategies in ischemic retinal lesions.

Authors:  Krisztina Szabadfi; Laszlo Mester; Dora Reglodi; Peter Kiss; Norbert Babai; Boglarka Racz; Krisztina Kovacs; Aliz Szabo; Andrea Tamas; Robert Gabriel; Tamas Atlasz
Journal:  Int J Mol Sci       Date:  2010-02-03       Impact factor: 6.208

8.  Calcium dysregulation induces apoptosis-inducing factor release: cross-talk between PARP-1- and calpain-signaling pathways.

Authors:  Peter S Vosler; Dandan Sun; Suping Wang; Yanqin Gao; Douglas B Kintner; Armando P Signore; Guodong Cao; Jun Chen
Journal:  Exp Neurol       Date:  2009-05-07       Impact factor: 5.330

9.  Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke.

Authors:  Mike Yuan; Chad Siegel; Zhiyuan Zeng; Jun Li; Fudong Liu; Louise D McCullough
Journal:  Exp Neurol       Date:  2009-03-05       Impact factor: 5.330

10.  Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia.

Authors:  Ji H Park; Aaron Long; Katrina Owens; Tibor Kristian
Journal:  Neurobiol Dis       Date:  2016-07-15       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.